Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs11750565 | chr5:1811318 | T/G | 5.72E-6 | 133 | 42.27 | 43.9 | 24.73 | KM Plot |
| TGCT | rs11775854 | chr8:103072851 | A/C | 0.000112 | 134 | 42.18 | 32.18 | 48.45 | KM Plot |
| TGCT | rs11778285 | chr8:103128351 | C/G | 1.55E-8 | 128 | 42.1 | 40.23 | 20.6 | KM Plot |
| TGCT | rs11778337 | chr8:103128349 | G/A | 1.55E-8 | 128 | 42.1 | 40.23 | 20.6 | KM Plot |
| TGCT | rs11784583 | chr8:103085037 | G/T | 0.00011 | 134 | 42.27 | 28.27 | 48.45 | KM Plot |
| TGCT | rs11787231 | chr8:96457033 | G/A | 1.64E-5 | 134 | 45.1 | 35.37 | 19.23 | KM Plot |
| TGCT | rs117944677 | chr7:128698185 | A/T | 1.87E-5 | 133 | 42.18 | 30.3 | 17.1 | KM Plot |
| TGCT | rs11801716 | chr1:42143899 | C/T | 0 | 133 | 42.1 | 25.33 | 0.57 | KM Plot |
| TGCT | rs11816485 | chr10:1147974 | T/C | 1.35E-13 | 134 | 42.03 | 66.9 | 17.1 | KM Plot |
| TGCT | rs11818314 | chr10:1148157 | G/C | 1.35E-13 | 134 | 42.03 | 66.9 | 17.1 | KM Plot |
| TGCT | rs11819230 | chr10:1128812 | A/G | 1.75E-13 | 133 | 42.03 | 70.63 | 17.1 | KM Plot |
| TGCT | rs11850235 | chr14:78267944 | T/C | 7.3E-5 | 134 | 45.83 | 37.95 | 18.07 | KM Plot |
| TGCT | rs11873578 | chr18:32792429 | T/A | 9.74E-5 | 132 | 17.1 | 27.1 | 50.97 | KM Plot |
| TGCT | rs11922084 | chr3:125630876 | C/G | 2.17E-5 | 132 | 51.32 | 35.37 | 52.43 | KM Plot |
| TGCT | rs11961196 | chr6:41344962 | A/C | 1.2E-6 | 130 | 45.1 | 25.77 | 11.53 | KM Plot |